Base10 Genetics announces Dr. Elizabeth Burns New Board Member
Dahlia Imanbay June 29, 2021

BASE10 welcomes Dr. Elizabeth Burns as a new member to the Board of Directors.

Dr. Burns brings over 21 years of healthcare industry experience to assist BASE10 in its expansionStay Gold Logo (1) as a disease management platform into the $134 billion dollar nursing home industry. She is presently Chief Medical Officer at Avamere Family of Companies, where she has led and transformed the COVID response and recovery in the post-acute and senior living space. Dr. Burns’ career spans from hospital-based medicine to the development of a cardiac and pulmonary rehabilitation program with an emphasis on secondary risk reduction. She also served as the Senior Executive Medical Director with Regence BlueCross Blue Shield/Cambia Health Solutions overseeing Medical Management and Medical Policy while transforming prior authorization through tech enabled solutions.

Dr. Elizabeth Burns: "It’s an honor to join the team at BASE10 that serves as a catalyst in healthcare transformation through innovative solutions. Company’s mission and mine align in creating an economically sustainable, personalized and patient centered system focused on improving patient outcomes."  

Tags

Base10 genetics
Foundation medicine
Dr. elizabeth burns
Dr. burns
Avamere